» Articles » PMID: 37304262

Reactive Oxygen Species Formation and Its Effect on CD4 T Cell-mediated Inflammation

Overview
Journal Front Immunol
Date 2023 Jun 12
PMID 37304262
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species (ROS) are produced both enzymatically and non-enzymatically . Physiological concentrations of ROS act as signaling molecules that participate in various physiological and pathophysiological activities and play an important role in basic metabolic functions. Diseases related to metabolic disorders may be affected by changes in redox balance. This review details the common generation pathways of intracellular ROS and discusses the damage to physiological functions when the ROS concentration is too high to reach an oxidative stress state. We also summarize the main features and energy metabolism of CD4 T-cell activation and differentiation and the effects of ROS produced during the oxidative metabolism of CD4 T cells. Because the current treatment for autoimmune diseases damages other immune responses and functional cells in the body, inhibiting the activation and differentiation of autoreactive T cells by targeting oxidative metabolism or ROS production without damaging systemic immune function is a promising treatment option. Therefore, exploring the relationship between T-cell energy metabolism and ROS and the T-cell differentiation process provides theoretical support for discovering effective treatments for T cell-mediated autoimmune diseases.

Citing Articles

The Role of Reactive Oxygen Species in Colorectal Cancer Initiation and Progression: Perspectives on Theranostic Approaches.

Catalano T, Selvaggi F, Cotellese R, Aceto G Cancers (Basel). 2025; 17(5).

PMID: 40075600 PMC: 11899472. DOI: 10.3390/cancers17050752.


Ferroptosis of T cell in inflammation and tumour immunity.

Xia X, Wu H, Chen Y, Peng H, Wang S Clin Transl Med. 2025; 15(3):e70253.

PMID: 40045458 PMC: 11882479. DOI: 10.1002/ctm2.70253.


Free radicals and their impact on health and antioxidant defenses: a review.

Chandimali N, Bak S, Park E, Lim H, Won Y, Kim E Cell Death Discov. 2025; 11(1):19.

PMID: 39856066 PMC: 11760946. DOI: 10.1038/s41420-024-02278-8.


Enhanced ROS Production and Mitochondrial Metabolic Shifts in CD4 T Cells of an Autoimmune Uveitis Model.

Soth R, Hoffmann A, Deeg C Int J Mol Sci. 2024; 25(21).

PMID: 39519064 PMC: 11545935. DOI: 10.3390/ijms252111513.


Differential Regulation of Wingless-Wnt/c-Jun N-Terminal Kinase Crosstalk via Oxidative Eustress in Primary and Metastatic Colorectal Cancer Cells.

Aceto G, Pagotto S, Del Pizzo F, Saoca C, Selvaggi F, Visone R Biomedicines. 2024; 12(8).

PMID: 39200280 PMC: 11351841. DOI: 10.3390/biomedicines12081816.


References
1.
Wen S, He L, Zhong Z, Zhao R, Weng S, Mi H . Stigmasterol Restores the Balance of Treg/Th17 Cells by Activating the Butyrate-PPARγ Axis in Colitis. Front Immunol. 2021; 12:741934. PMC: 8526899. DOI: 10.3389/fimmu.2021.741934. View

2.
Morris G, Anderson G, Dean O, Berk M, Galecki P, Martin-Subero M . The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol. 2014; 50(3):1059-84. DOI: 10.1007/s12035-014-8705-x. View

3.
Eriksson U, Kurrer M, Sebald W, Brombacher F, Kopf M . Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J Immunol. 2001; 167(9):5464-9. DOI: 10.4049/jimmunol.167.9.5464. View

4.
Zhang J, Tripathi D, Jing J, Alexander A, Kim J, Powell R . ATM functions at the peroxisome to induce pexophagy in response to ROS. Nat Cell Biol. 2015; 17(10):1259-1269. PMC: 4589490. DOI: 10.1038/ncb3230. View

5.
Surmeier D, Guzman J, Sanchez J, Schumacker P . Physiological phenotype and vulnerability in Parkinson's disease. Cold Spring Harb Perspect Med. 2012; 2(7):a009290. PMC: 3385938. DOI: 10.1101/cshperspect.a009290. View